TRLV
Trulieve Cannabis Corp.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
9.60
close · 2026-08-13
value
66
cheaper than peers66
quality
25
stronger fundamentals25
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 6.42× | 90 |
| price to book | 1.58× | 78 |
| price to sales | 1.53× | 73 |
| forward P/E | 22.86× | 13 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 12.8% | 69 |
| debt to equity | 75.4% | 60 |
| revenue growth | -10.3% | 14 |
| return on equity | -47.6% | 13 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $231.8M |
| employees | 5,000 |
| first trade | 2018-09-27 |
| next earnings | 2026-08-07 |
| fundamentals updated | 2026-08-10 |